The AMPA antagonist ZK 200775 in patients with acute ischaemic stroke : A double-blind, multicentre, placebo-controlled safety and tolerability study

Walters,Markku Kaste,Kennedy R. Lees,H.-C. Diener,Marc Hommel,J De Keyser,H Steiner,Mark Versavel

The AMPA antagonist ZK 200775 in patients with acute ischaemic stroke : A double-blind, multicentre, placebo-controlled safety and tolerability study

2005

Walters
Markku Kaste
Kennedy R. Lees
H.-C. Diener
Marc Hommel
J De Keyser
H Steiner
Mark Versavel

Background and Purpose: ZK 200775 is a selective competitive AMPA receptor antagonist. It has demonstrated neuroprotective efficacy in experimental models of stroke and tolerability

Keywords:

Antagonist
Placebo
Tolerability Study
Diabetes mellitus
Glasgow Coma Scale
Anesthesia
Blood pressure
Medicine
Stroke
Tolerability
AMPA receptor
Neuroprotection

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations